World Class Innovators and Researchers
Putting the “sleep” back into sleep medicine
Cerebra is a Canadian technology company transforming the future of sleep diagnosis and therapy. Cerebra unites innovators and researchers with the common goal and passion of putting “sleep” back into sleep medicine.
How we are Transforming the Future of Sleep
Cerebra Sleep System uses the patented algorithm, Odds Ratio Product (ORP) that micro analyses the Electroencephalogram (EEG) signal providing a continuous measure of sleep depth, moving beyond conventional scoring methods to dig deeper into brain activity.
As a leader in sleep diagnostic technology, our innovative Cerebra Sleep System provides sleep researchers and clinicians with accurate, self-applied, in-home diagnostics.
With the expertise of our talented cross functional team and our world class Scientific Advisory Board lead by Dr. Magdy Younes, Cerebra is transforming sleep diagnostics enabling personalized patient treatment for improved physical, mental and emotional health outcomes.
The Journey to Bring the Sleep Lab to the Home
The Cerebra Story begins with our scientific founder, Dr. Magdy Younes MD, FRCPC, PhD. He recognized that sleep medicine was lagging behind other fields in the application of digital technology and as a result, patient care suffered.
In 2013, Dr. Younes developed a new patented algorithm, Odds Ratio Product (ORP) that micro analyses the Electroencephalogram (EEG) signal providing a continuous measure of sleep depth moving beyond conventional scoring methods to dig deeper into brain activity during sleep.
Cerebra conquered a major impediment to sleep research through developing the most advanced in-home, self-applied, lab quality full diagnostic Polysomnography (PSG). Bringing sleep diagnostics to the home became a reality with Cerebra Sleep System using the patented ORP Sleep Architecture.
In 2021, Cerebra formed a world class Scientific Advisory Board to enhance sleep diagnostics and to lead to the development of future sleep technologies and therapeutics.
